Home Search Abstracts Browse Sessions Program Committee Conference Webcasts Contact Us

 

 

 

Session 93  Poster Abstracts
Therapeutic Vaccination of Infected Patients
Friday, 1:30 - 3:30 pm
Hall A
      524 Relative Effects of Therapeutic Immunization and Discontinuation of ART on HIV-1-specific CD4 and CD8 T Cells Producing Interferon-G in ART-treated Acutely Infected Subjects (QUEST Study)
Assia Samri*1, F Lampe2, S Kinloch-De Loes2, A Phillips2, L Perrin3, D Cooper4, L Goh5, B Hoen6, J Andersson7, A Sonnerborg7, D Smith4, C Tsoukas8, R El Habib9, G Theofan10, and B Autran1
1INSERM U543, Hosp Pitie-Salpetriere, Paris, France; 2Royal Free and Univ Coll, London, UK; 3Geneva Univ Hosp, Switzerland; 4Natl Ctr in HIV Epidemiology and Clin Res, Univ of New South Wales, Sydney, Australia; 5GlaxoSmithKline, Greenford, UK; 6CMU Besancon, France; 7Karolinska Inst, Stockholm, Sweden; 8McGill Univ, Montreal, Canada; 9Aventis Pasteur, Lyon, France; and 10Immune Response Corp, Carlsbad, CA
      525 A Phase II Randomized, Partially Blinded Trial of Antiretroviral Therapy, HIV-specific Immunizations, and IL-2 Cycles to Promote Efficient Control of Viral Replication (ACTG A5024)
J Michael Kilby*1, R Wang2, D Mildvan3, M Fischl4, J Santana-Bagur5, C Pilcher6, A Zolopa7, J Lawrence8, R Pollard9, R Bosch2, R Bucy1, R Mitsuyasu10, and The ACTG A5024 Protocol Team
1Univ of Alabama at Birmingham, USA; 2Harvard Univ, Boston, MA, USA; 3Beth Israel Deaconess Med Ctr, Boston, MA, USA; 4Univ of Miami, FL, USA; 5Univ of Puerto Rico, San Juan; 6Univ of North Carolina at Chapel Hill, USA; 7Stanford Univ, CA, USA; 8Univ of California, San Francisco, USA; 9Univ of California, Davis, USA; and 10Univ of California, Los Angeles, USA
      526 Therapeutic Immunization with MVA.HIVA, a Recombinant Modified Vaccinia Virus Ankara / HIV-1 Gag Polyepitope Vaccine, in HIV-1-infected Subjects Receiving HAART
Lucy Dorrell*1, H Yang1, B Ondondo1, T Dong1, A Iversen1, K de Gleria1, A Suttill2, C Conlon3, T Rostron1, P Bowness1, S Rowland-Jones1, T Hanke1, and A McMichael1
1Weatherall Inst of Molecular Med, Oxford, UK; 2Genito-Urinary Med, Oxford, UK; and 3Univ of Oxford, UK
      527 Immunogenicity of a Multi-epitope-based DNA Vaccine in HIV-1-infected Subjects Receiving Potent Antiretroviral Therapy
Cara Wilson*1, B Livingston2, S MaWhinney1, R Schooley1, J Forster1, M Anders1, N Blyveis1, J Scott1, M Newman2, and C Benson1
1Univ of Colorado Hlth Sci Ctr, Denver, USA and 2Epimmune, San Diego, CA, USA